Solazyme Inc. (NASDAQ:TVIA) shares shot up 3.8% during mid-day trading on Thursday . The stock traded as high as $2.78 and last traded at $2.75, with a volume of 358,397 shares traded. The stock had previously closed at $2.65.

The stock’s market cap is $234.35 million. The stock has a 50-day moving average of $2.55 and a 200 day moving average of $2.24.

Solazyme (NASDAQ:TVIA) last issued its earnings results on Monday, August 8th. The company reported ($0.26) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.29) by $0.03. During the same quarter in the prior year, the company posted $0.40 earnings per share. The firm earned $9.90 million during the quarter, compared to analysts’ expectations of $10.85 million. Solazyme’s quarterly revenue was down 15.4% compared to the same quarter last year. Equities analysts anticipate that Solazyme Inc. will post ($1.15) EPS for the current fiscal year.

In other Solazyme news, CFO Tyler Painter sold 12,500 shares of the company’s stock in a transaction on Tuesday, June 7th. The stock was sold at an average price of $2.67, for a total value of $33,375.00. Following the completion of the sale, the chief financial officer now directly owns 400,337 shares in the company, valued at approximately $1,068,899.79. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Solazyme, Inc creates renewable oils and bioproducts. The Company’s technology uses microalgae in an industrial fermentation process to transform a range of plant-based sugars into triglyceride oils and other bioproducts. The Company offers Algenist, a skin and personal care product available at Sephora SA and its affiliates, QVC, Inc, SpaceNK Limited, select Nordstrom stores and ULTA Beauty.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.